INCREASE IN CIRCULATING AND NEUTROPHIL-MEDIATED RELEASE OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IN PATIENTS WITH ADVANCED HEART FAILURE
Diana Chaar(Montreal Heart Institute), Malka R. White, Normand Racine(Montreal Heart Institute), M. Lizkowski(Montreal Heart Institute), Marco Sirois, Paul‐Eduard Neagoe(Montreal Heart Institute), Damien Vitiello(Délégation Paris 5), Geneviève Pelletier(Université Laval), M. Carrier(Montreal Heart Institute), Anique Ducharme(Montreal Heart Institute)
Cited by 0
Related Papers
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
|New England Journal of Medicine|2008|1.6k
Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction
|Circulation|2003|581
Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring
|Circulation|2019|570
F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction and Suspected Coronary Disease
|Journal of the American College of Cardiology|2007|476
A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial
|Journal of the American College of Cardiology|1999|385